Analyst Recommendations

Overweight Recommendation Issued On NEE By Barclays
Barclays analyst issues OVERWEIGHT recommendation for NEE on February 22, 2024 08:42AM ET. The previous analyst recommendation was Overweight.NEE was trading at $57.1 at issue of the analyst...

February 22, 2024   NEE -0.32%

Overweight Recommendation Issued On SRE By Barclays
Barclays analyst issues OVERWEIGHT recommendation for SRE on February 22, 2024 08:42AM ET. The previous analyst recommendation was Overweight.SRE was trading at $71.96 at issue of the analyst...

February 22, 2024   SRE -0.45%

Outperform Recommendation Issued On MRNA By Oppenheimer
Oppenheimer analyst issues OUTPERFORM recommendation for MRNA on February 22, 2024 02:32AM ET. The previous analyst recommendation was Neutral.MRNA was trading at $87.59 at issue of the analyst...

February 22, 2024   MRNA -1.87%

Equal-Weight Recommendation Issued On MRNA By Morgan Stanley
Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for MRNA on February 22, 2024 02:32AM ET. The previous analyst recommendation was Equal-Weight.MRNA was trading at $87.59 at issue of the...

February 22, 2024   MRNA -1.87%

Hold Recommendation Issued On MLM By HSBC
HSBC analyst issues HOLD recommendation for MLM on February 22, 2024 02:48AM ET. MLM was trading at $536.3 at issue of the analyst recommendation.The overall analyst consensus :...

February 22, 2024   MLM -0.42%

Sector Outperform Recommendation Issued On MOS By Scotiabank
Scotiabank analyst issues SECTOR OUTPERFORM recommendation for MOS on February 22, 2024 04:02AM ET. MOS was trading at $30.23 at issue of the analyst recommendation.The overall analyst consensus...

February 22, 2024   MOS 1.42%

Equal-Weight Recommendation Issued On MRNA By Morgan Stanley
Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for MRNA on February 22, 2024 02:32AM ET. The previous analyst recommendation was Equal-Weight.MRNA was trading at $87.59 at issue of the...

February 22, 2024   MRNA -1.87%

Hold Recommendation Issued On MRNA By Canaccord Genuity
Canaccord Genuity analyst issues HOLD recommendation for MRNA on February 22, 2024 02:32AM ET. MRNA was trading at $87.59 at issue of the analyst recommendation.The overall analyst consensus...

February 22, 2024   MRNA -1.87%

Hold Recommendation Issued On MRNA By Canaccord Genuity
Canaccord Genuity analyst issues HOLD recommendation for MRNA on February 22, 2024 02:32AM ET. MRNA was trading at $87.59 at issue of the analyst recommendation.The overall analyst consensus...

February 22, 2024   MRNA -1.87%

Outperform Recommendation Issued On MRNA By Oppenheimer
Oppenheimer analyst issues OUTPERFORM recommendation for MRNA on February 22, 2024 02:32AM ET. The previous analyst recommendation was Neutral.MRNA was trading at $87.59 at issue of the analyst...

February 22, 2024   MRNA -1.87%